{
    "nctId": "NCT01322412",
    "briefTitle": "Adapted Physical Activity Effect and Fatigue in Patients With Breast Cancer",
    "officialTitle": "Adapted Physical Activity Effect on Aerobic Function and Fatigue in Patients With Breast Cancer Treated in Adjuvant Phase",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 44,
    "primaryOutcomeMeasure": "main criterion is exercise tolerance at 27 weeks, measured by VO2 max, following a physical activity (PA) programme",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* females between 18 and 75 years of age\n* signed written informed consent\n* willing to take part in the trial and to follow the instructions\n* breast tumour, histologically documented\n* patients who have undergone curative surgery\n* patients for whom a 6-treatment course of adjuvant chemotherapy (3FEC100 + taxanes) and radiotherapy has been scheduled\n* patients with HER2-negative cancer.\n\nExclusion Criteria:\n\n* metastatic cancer\n* other primary tumours\n* disability preventing a proper understanding of the instructions for the trial\n* chemotherapy strictly contra-indicated\n* patients who are subject to a court protection, wardship or guardianship order\n* uncontrolled hypertension\n* family history of sudden death in a first-degree relative\n* unstabilised heart disease\n* current treatment with beta-blockers\n* chronic or acute pulmonary disease associated with dyspnoea upon moderate effort\n* uncontrolled thyroid dysfunction\n* uncontrolled diabetes\n* any other serious conditions that are unstabilised, disabling or in which physical exercise is contra-indicated\n* unable to attend for follow-up throughout the duration of the study\n* ventricular ejection fraction (vef) \\< 50%, pregnancy or suckling.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}